Press Releases Print Email
All Releases
View Summary VIVUS to Host Analyst Day Webcast on Thursday, May 18th
May 16, 2006
PDF 12.4 KB Add to Briefcase
View Summary VIVUS Announces Positive Phase 2 Clinical Trial Results With Qnexa, a Novel Therapy to Treat Obesity
May 10, 2006
PDF 17.0 KB Add to Briefcase
View Summary VIVUS to Raise $12 Million in Registered Direct Offering of Common Stock
May 10, 2006
PDF 12.9 KB Add to Briefcase
View Summary VIVUS to Host Conference Call & Webcast on Wednesday, May 10th
May 9, 2006
PDF 12.3 KB Add to Briefcase
View Summary VIVUS to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference
May 8, 2006
PDF 11.5 KB Add to Briefcase
View Summary VIVUS Announces Positive Phase 3 Clinical Trial Results for Evamist(TM) - The First Transdermal Spray for the Treatment of Menopausal Symptoms
May 5, 2006
PDF 14.3 KB Add to Briefcase
View Summary VIVUS Reports First Quarter 2006 Financial Results and Product Development Highlights
Apr 27, 2006
PDF 18.8 KB Add to Briefcase
View Summary VIVUS Announces First Quarter 2006 Financial Results Conference Call
Apr 21, 2006
PDF 11.3 KB Add to Briefcase
View Summary VIVUS to Present at Cowen & Co. 26th Annual Health Care Conference
Mar 2, 2006
PDF 10.8 KB Add to Briefcase
View Summary VIVUS Announces Grant of Key Patent for MDTS® Delivery System
Mar 1, 2006
PDF 12.5 KB Add to Briefcase
View Summary VIVUS Reports 2005 Fourth Quarter and Full-Year Financial Results
Feb 23, 2006
PDF 22.6 KB Add to Briefcase
View Summary VIVUS Announces Fourth Quarter and Full Year 2005 Financial Results Conference Call
Feb 16, 2006
PDF 11.3 KB Add to Briefcase
View Summary VIVUS to Present at BIO CEO & Investor Conference
Feb 10, 2006
PDF 11.1 KB Add to Briefcase
View Summary VIVUS Announces FDA Acceptance of EvaMist(TM) NDA Submission
Jan 12, 2006
PDF 13.5 KB Add to Briefcase
Showing 421-434 of 434 Page: 1 ... 20 21 22  Previous 20
= add release to Briefcase